Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients
- 13 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical and Translational Oncology
- Vol. 22 (11), 2040-2048
- https://doi.org/10.1007/s12094-020-02345-3
Abstract
Background Although the chemotherapy-induced depletion of circulating white blood cells (WBC) is well recognized, the impact of exclusive radiotherapy (RT) on the different subpopulations of WBC remains unexplored. This may be important for immunotherapy administrated in combination with radiation, especially in malignant tumors usually treated with RT or chemoradiotherapy (CRT), and characterized by a high mutational burden, such as endometrial (EC) or cervical cancer (CC). We aimed to evaluate the impact of RT and CRT on circulating WBC in uterine cancers and its correlation with survival. Material and methods A total of 202 consecutive patients with uterine cancers treated with RT or CRT between 2009 and 2016 in a large European center and with available basal and post-treatment blood tests were retrospectively evaluated. EC and CC patients were analyzed separately. The differences between pre- and post- treatment WBC mean values were evaluated independently in patients treated with CRT and exclusive RT. Two-sided T test for paired samples and Kaplan–Meier curves were applied for analysis (p value < 0.05, SPSS v.23). Results Among EC patients, 29 received CRT and 34 exclusive postoperative RT, while in CC cohort, 105 were treated with CRT and 34 with RT. In both cohorts, CRT affected significantly all WBC subtypes, whereas exclusive RT decreased only lymphocytes population (p = 0.000). Radiation-induced lymphopenia (RIL) had no impact on survival outcomes. Conclusions The selective depletion of lymphocytes after RT was significant in both EC and CC. Our results are of interest for further research on RIL and for design of immunotherapy-based clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)European Journal of Cancer, 2017
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trialThe Lancet Oncology, 2017
- Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?International Journal of Radiation Oncology*Biology*Physics, 2016
- Lymphopenia and its association with survival in patients with locally advanced cervical cancerGynecologic Oncology, 2015
- Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid TumorsJournal of the National Comprehensive Cancer Network, 2015
- Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancerTumor Biology, 2015
- PD-1, PD-L1 expression in 1599 gynecological cancers: Implications for immunotherapyGynecologic Oncology, 2015
- Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient OutcomesInternational Journal of Radiation Oncology*Biology*Physics, 2014
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm ShiftJNCI Journal of the National Cancer Institute, 2013
- RADIATION‐INDUCED IMMUNE CHANGES IN PATIENTS WITH CANCER OF THE CERVIXBJOG: An International Journal of Obstetrics and Gynaecology, 1976